Compare · BFLY vs HOLX
BFLY vs HOLX
Side-by-side comparison of Butterfly Network Inc. (BFLY) and Hologic Inc. (HOLX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BFLY and HOLX operate in Medical Electronics (Health Care), so they compete in similar markets.
- HOLX is the larger of the two at $17.60B, about 7.3x BFLY ($2.41B).
- BFLY has hit the wire 14 times in the past 4 weeks while HOLX has been quiet.
- HOLX has more recent analyst coverage (25 ratings vs 8 for BFLY).
- Company
- Butterfly Network Inc.
- Hologic Inc.
- Price
- -
- -
- Market cap
- $2.41B
- $17.60B
- 1M return
- +27.50%
- -
- 1Y return
- +468.55%
- -
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- 1990
- News (4w)
- 14
- 0
- Recent ratings
- 8
- 25
Butterfly Network Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
Hologic Inc.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima quantitative viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. It has a collaboration with RadNet, Inc. to advance the use of artificial intelligence in breast health. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.
Latest BFLY
- President & CEO Devivo Joseph gifted 250,000 shares, decreasing direct ownership by 3% to 7,353,700 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.
- Director Robbins Larry sold $20,622,493 worth of shares (2,297,733 units at $8.98) (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.
- Director Phanstiel S. Louise bought $999,510 worth of shares (115,200 units at $8.68) (SEC Form 4)
- SEC Form SCHEDULE 13G filed by Butterfly Network Inc.
- Deputy General Counsel Caezza Nicholas sold $97,500 worth of shares (10,000 units at $9.75), decreasing direct ownership by 3% to 300,307 units (SEC Form 4)
- President & CEO Devivo Joseph sold $684,075 worth of shares (68,346 units at $10.01) as part of a pre-agreed trading plan, decreasing direct ownership by 0.89% to 7,603,700 units (SEC Form 4)
- Butterfly Network Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 144 filed by Butterfly Network Inc.
Latest HOLX
- SEC Form 15-12G filed by Hologic Inc.
- SEC Form EFFECT filed by Hologic Inc.
- SEC Form EFFECT filed by Hologic Inc.
- SEC Form 4 filed by Verstreken Jan
- SEC Form 4 filed by Schnittker Brandon
- SEC Form 4 filed by Schneiders Jennifer M
- SEC Form 4 filed by Oberton Karleen Marie
- SEC Form 4 filed by Mitchell Essex D
- SEC Form 4 filed by Liddy Anne M.
- SEC Form 4 filed by Horvath Mark W.